An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)
Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and the United States of America (USA). The aim of the
trial is to investigate the safety and tolerability of NNC0114-0006 in subjects with systemic
lupus erythematosus (SLE) concomitantly treated with stable background therapies.